Christopher G. Smith

Mismatch Repair Status and <i>BRAF</i> Mutation Status in Metastatic Colorectal Cancer Patients: A Pooled Analysis of the CAIRO, CAIRO2, COIN, and FOCUS Studies

Sabine Venderbosch, Irıs D. Nagtegaal, Tim Maughan et al. · Clinical Cancer Research · 2014 · 741 citations

Medicine, Cancer Biology, Oncology +17

Investigating the poor outcomes ofBRAF-mutant advanced colorectal cancer: analysis from 2530 patients in randomised clinical trials

Jenny F. Seligmann, David J. Fisher, Christopher G. Smith et al. · Annals of Oncology · 2016 · 165 citations · Full text

Medicine, Molecular Medicine, Oncology +8

Transvaginal Ultrasound Can Accurately Predict the American Society of Reproductive Medicine Stage of Endometriosis Assigned at Laparoscopy

Mathew Leonardi, Mercedes Espada, Sarah Choi et al. · Journal of Minimally Invasive Gynecology · 2020 · 60 citations

Medicine, Gynecology, Obstetrics +17

<i>BRAF</i> and <i>NRAS</i> Locus-Specific Variants Have Different Outcomes on Survival to Colorectal Cancer

Matthew G. Summers, Christopher G. Smith, Tim Maughan et al. · Clinical Cancer Research · 2016 · 38 citations

Medicine, Genetics, Oncology +17

Use of epiregulin (EREG) and amphiregulin (AREG) gene expression to predict response to cetuximab (cet) in combination with oxaliplatin (Ox) and 5FU in the first-line treatment of advanced colorectal cancer (aCRC).

Richard Adams, David J. Fisher, Susan Farragher et al. · Journal of Clinical Oncology · 2012 · 27 citations

Medicine, Oncology, Pharmacology +17